Australia’s National Lung Cancer Screening Program (NLCSP) is a landmark public health initiative aimed at detecting lung cancer at its earliest and most treatable stages. Launching in July 2025, the program targets individuals at high risk of lung cancer, offering low-dose CT (LDCT) screening every two years. Early detection through screening has been shown to significantly reduce mortality by identifying cancers before symptoms appear.
Who is Eligible?
Entry into the program is based on a risk assessment that considers smoking history and age. To be eligible, individuals must:
- Be aged 50 to 70 years
- Have a history of significant smoking exposure (measured in pack-years)
- Be current or former smokers who quit within the past 15 years
Eligible participants are referred for a low-dose CT chest scan at an accredited imaging provider.
Why Choose GARRAN MEDICAL IMAGING in Partnership with Lungscreen Australia?
As a proud contributor to the NLCSP, GARRAN MEDICAL IMAGING has partnered with Lungscreen Australia to deliver an industry-leading lung screening solution—built on clinical rigour, technological innovation, and personalised care.
Specialist Reporting by Respiratory Radiologists
All scans are interpreted by radiologists with dedicated training in respiratory imaging. Combined with AI-enhanced tools, this ensures consistently high diagnostic accuracy and standardised follow-up aligned with national guidelines.
Australia’s Only Purpose-Built Lung Screening Platform
We operate the only imaging platform in Australia designed specifically for lung cancer screening. This system integrates all previous chest imaging into one environment, allowing true temporal comparisons across time. Combined with standardised low-dose protocols, this leads to more reliable reporting and long-term monitoring.
Dedicated Clinical Support for Referrers
In collaboration with Lungscreen Australia, referring clinicians benefit from access to a Respiratory Nurse Navigator—an experienced professional available to help interpret reports, coordinate follow-up, and support decision-making in complex cases.
A Better Screening Experience—For Clinicians and Patients
By partnering with Lungscreen Australia, GARRAN MEDICAL IMAGING is delivering more than just scans—we’re delivering a complete clinical service that helps save lives. Referrers can trust that their patients will receive expert, end-to-end care aligned with the goals of the NLCSP.
For more information or to refer a patient, contact us or visit https://www.health.gov.au/our-work/nlcsp/about